These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25819414)

  • 1. Glucose metabolism provide distinct prosurvival benefits to non-small cell lung carcinomas.
    Wu R; Galan-Acosta L; Norberg E
    Biochem Biophys Res Commun; 2015 May; 460(3):572-7. PubMed ID: 25819414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Heterogeneity in Human Lung Tumors.
    Hensley CT; Faubert B; Yuan Q; Lev-Cohain N; Jin E; Kim J; Jiang L; Ko B; Skelton R; Loudat L; Wodzak M; Klimko C; McMillan E; Butt Y; Ni M; Oliver D; Torrealba J; Malloy CR; Kernstine K; Lenkinski RE; DeBerardinis RJ
    Cell; 2016 Feb; 164(4):681-94. PubMed ID: 26853473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
    Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
    Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.
    Meijer TWH; Looijen-Salamon MG; Lok J; van den Heuvel M; Tops B; Kaanders JHAM; Span PN; Bussink J
    Thorac Cancer; 2019 Dec; 10(12):2289-2299. PubMed ID: 31668020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer.
    Meijer TWH; Peeters WJM; Dubois LJ; van Gisbergen MW; Biemans R; Venhuizen JH; Span PN; Bussink J
    Lung Cancer; 2018 Dec; 126():32-40. PubMed ID: 30527190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.
    Yatabe Y; Masuda A; Koshikawa T; Nakamura S; Kuroishi T; Osada H; Takahashi T; Mitsudomi T; Takahashi T
    Cancer Res; 1998 Mar; 58(5):1042-7. PubMed ID: 9500468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer.
    Walter K; Holcomb T; Januario T; Du P; Evangelista M; Kartha N; Iniguez L; Soriano R; Huw L; Stern H; Modrusan Z; Seshagiri S; Hampton GM; Amler LC; Bourgon R; Yauch RL; Shames DS
    Clin Cancer Res; 2012 Apr; 18(8):2360-73. PubMed ID: 22261801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
    Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
    Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
    Liu C; Tsao MS
    Am J Pathol; 1993 Feb; 142(2):413-23. PubMed ID: 8382008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced glycometabolism as a mechanism of NQO1 potentiated growth of NSCLC revealed by metabolomic profiling.
    Cheng X; Liu F; Liu H; Wang G; Hao H
    Biochem Biophys Res Commun; 2018 Jan; 496(1):31-36. PubMed ID: 29291405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
    Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
    Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients.
    Nakashima T; Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Huang CL
    Oncol Rep; 2008 Jan; 19(1):203-9. PubMed ID: 18097596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argpyrimidine-modified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis.
    van Heijst JW; Niessen HW; Musters RJ; van Hinsbergh VW; Hoekman K; Schalkwijk CG
    Cancer Lett; 2006 Sep; 241(2):309-19. PubMed ID: 16337338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation.
    Suzuki M; Shiraishi K; Yoshida A; Shimada Y; Suzuki K; Asamura H; Furuta K; Kohno T; Tsuta K
    Lung Cancer; 2015 Jan; 87(1):14-22. PubMed ID: 25468202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.